Richard C Hellwig, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 795 Middle St, Fall River, MA 02721 Phone: 508-235-5226 Fax: 508-675-5687 |
Marilyn E Miller, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 795 Middle St, Fall River, MA 02721 Phone: 508-235-5226 Fax: 508-675-5687 |
J. Bruno Pestana, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 795 Middle Street, St. Anne's Hospital, Fall River, MA 02721 Phone: 508-235-5226 |
Miss Sonia M Seng, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 506 Prospect Street, Fall River, MA 02720 Phone: 508-973-7888 Fax: 508-973-7934 |
Mark Shparber, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 506 Prospect Street, Fall River, MA 02720 Phone: 508-973-7888 Fax: 508-973-7834 |
Therese M. Mulvey, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-679-7234 Fax: 508-679-7029 |
Nancy Felty Mckinney, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 795 Middle Street, St Anne's Hospital Hudner Oncology Center, Fall River, MA 02720 Phone: 508-235-5226 Fax: 508-235-5687 |
News Archive
The U.S. Food and Drug Administration today approved a medical device that supports the weakened heart of children with heart failure to help keep them alive until a donor for a heart transplant can be found.
Elderly patients caught between U.S. hospitals and Medicare auditors pushing to cut costs are increasingly facing tens of thousands of dollars in unexpected medical bills.
Online support communities appear to offer both a valuable educational resource and a source of psychological and social support for individuals with psoriasis, according to a report in the January issue of Archives of Dermatology.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
› Verified 8 days ago